Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 26, Johnson & ...
Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...
MedPage Today on MSN
Assisted Reproduction Linked to Child's Risk of Asthma, Eczema
Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...
A recently approved injectable eczema drug, Nemluvio, provides quick itch relief to patients with the maddening skin disease, ...
Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...
Eczema is a skin condition that people have for a time. It is also known as atopic dermatitis. Eczema makes your skin dry and ...
Vietnam Investment Review on MSN
Eczema causes festive isolation for some Singaporeans during gatherings
Skin condition flare-ups during the humid season are leading some individuals to avoid social events and celebrations.
Stocktwits on MSN
Johnson & Johnson terminates experimental eczema drug study after it fails to show benefit
The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...
HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.
Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...
A new study from North Carolina State University found that neutrophils—white blood cells that are a key part of the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback